Brief: Kinnate Biopharma Inc. Provides Full-Year 2022 Financial Results And Recent Corporate Updates
15/03/2023 20:14
March 15 (Reuters) - Kinnate Biopharma Inc KNTE.O :
* KINNATE BIOPHARMA INC. PROVIDES FULL-YEAR 2022 FINANCIAL
RESULTS
AND RECENT CORPORATE UPDATES
* KINNATE BIOPHARMA INC - CASH, CASH EQUIVALENTS AND
INVESTMENTS
OF $266.3 MILLION AS OF DECEMBER 31, 2022
Source text for Eikon: ID:nGNXbqKMrs
Further company coverage: KNTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview